Dicyclomine hydrochloride NDC 0832-6052

NDC codes

FDA NDC Directory

Product NDC (as listed)0832-6052Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00832-6052Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0832-6052-11	00832605211	100 TABLET in 1 BOTTLE (0832-6052-11)Marketed from Feb 9, 2023

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Dicyclomine hydrochloride
Generic name (nonproprietary): dicyclomine hydrochloride
Active ingredients: Dicyclomine hydrochloride — 20 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Upsher-Smith Laboratories, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 216760
Marketing start: Nov 28, 2022
Marketing end: Sep 30, 2026
Other FDA classes: Cholinergic Antagonists (Mechanism)
Identifiers: Product ID 0832-6052_43687d93-357b-a540-e063-6394a90a2748SPL ID 43687d93-357b-a540-e063-6394a90a2748SPL set ID dda92fd9-d0e2-447b-aae6-012f089a4c2fRxCUI 991086UNII CQ903KQA31UPC 0308326052117
Pharmacologic class: Anticholinergic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400832605211 followed by a unit qualifier and the quantity

Package 00832-6052-11. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 12, 2025.

Indications (excerpt from the label)

Dicyclomine hydrochloride is indicated for the treatment of patients with functional bowel/irritable bowel syndrome. Dicyclomine hydrochloride is an antispasmodic and anticholinergic (antimuscarinic) agent indicated for the treatment of functional bowel/irritable bowel syndrome ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 216760

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 216760
Product	Strength	Form · route	Labeler	Product NDC
Dicyclomine Hydrochloride	Dicyclomine hydrochloride 20 mg/1	TabletOral	Solaris Pharma Corporation	73473-902
Dicyclomine Hydrochloride	Dicyclomine hydrochloride 20 mg/1	TabletOral	PD-Rx Pharmaceuticals, Inc.	72789-539